Aytu BioPharma, Inc. (AYTU:NASDAQ) closed at $1.96 on October 21, 2026, down 2.49% on the day. The stock trades 36.2% below its 52-week high of $3.07 and 8.9% above its 52-week low of $1.80. Over the past year, it lost 13.7%. Aytu BioPharma, Inc. is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, AYTU closed higher on 120 days (48%). Its best day was June 18, 2026 (+9.48%) and its worst was February 4, 2026 (-10.31%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.
Find more stocks like AYTU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.